financetom
Business
financetom
/
Business
/
Baring Private Equity Asia acquires 30% stake in NIIT Technologies for Rs 2,627 crore
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Baring Private Equity Asia acquires 30% stake in NIIT Technologies for Rs 2,627 crore
May 18, 2019 7:39 AM

Baring Private Equity Asia (BPEA) has acquired 30.50 percent stake in mid-sized software services firm NIIT Technologies Ltd for about Rs 2,627 crore, a regulatory filing said Saturday.

Last month, funds affiliated with BPEA had signed definitive agreements to purchase 30.5 percent stake in NIIT Technologies from NIIT Ltd and other promoter entities at Rs 1,394 per share.

In a filing to BSE Saturday, NIIT Technologies said Hulst B.V. acquired 18,848,118 equity shares of the company with the face value of Rs 10 each on May 17. The Netherlands-registered Hulst B.V. is indirectly owned by funds affiliated with BPEA.

Following the stake transfer, the firm's chairman Rajendra Singh Pawar, vice chairman and managing director Arvind Thakur and non-executive director Vijay Kumar Thadani have resigned from their positions as directors on the board with immediate effect, it added.

NIIT Technologies' promoters, which included NIIT Ltd and the families of Rajendra Pawar and Vijay Thadani, had a total of 30.04 percent stake in the company. NIIT Ltd directly held 23.1 percent stake.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Calidi Biotherapeutics Says FDA Clears Phase 1b/2 Trial of CLD-101 in High-Grade Glioma
Calidi Biotherapeutics Says FDA Clears Phase 1b/2 Trial of CLD-101 in High-Grade Glioma
Oct 2, 2024
09:02 AM EDT, 09/30/2024 (MT Newswires) -- Calidi Biotherapeutics ( CLDI/WS ) said Monday that the US Food and Drug Administration has cleared Northwestern University's investigational new drug application for the company's CLD-101 therapy, which uses stem cells to deliver engineered oncolytic adenoviruses. A phase 1b/2 trial of the investigational treatment is expected to begin late this year at the...
Sector Update: Consumer Stocks Steady Pre-Bell Monday
Sector Update: Consumer Stocks Steady Pre-Bell Monday
Oct 2, 2024
09:03 AM EDT, 09/30/2024 (MT Newswires) -- Consumer stocks were steady pre-bell Monday with the Consumer Staples Select Sector SPDR Fund ( XLP ) and Consumer Discretionary Select Sector SPDR Fund ( XLY ) recently inactive. Yunji ( YJ ) shares were up over 15% after the company regained compliance with Nasdaq's minimum bid price requirement for continued listing. Jack...
Osisko Gold Acquires Royalties on Dalgaranga Gold Project in Australia for $50 Million
Osisko Gold Acquires Royalties on Dalgaranga Gold Project in Australia for $50 Million
Oct 2, 2024
09:03 AM EDT, 09/30/2024 (MT Newswires) -- Osisko Gold Royalties ( OR ) said on Monday that it had agreed to acquire a 1.8% gross revenue royalty on the Dalgaranga Gold project in Western Australia, operated by Spartan Resources Limited The company said it also acquired a 1.35% gross revenue royalty on nearby exploration licenses to Dalgaranga. Osisko Gold Royalties...
American Water Works Says Pennsylvania Court Dismisses Challenge to  Wastewater Asset Acquisition
American Water Works Says Pennsylvania Court Dismisses Challenge to Wastewater Asset Acquisition
Oct 2, 2024
09:02 AM EDT, 09/30/2024 (MT Newswires) -- American Water Works ( AWK ) said Friday the Pennsylvania Commonwealth Court has dismissed appeals challenging the Pennsylvania Public Utility Commission's approval of its $230 million acquisition of Butler Area Sewer Authority's wastewater assets. Following the court decision, American Water Works ( AWK ) said its subsidiary Pennsylvania-American Water will move forward to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved